Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 658

Results For "ALS"

7995 News Found

Community approach crucial to stamp out diseases
Public Health | March 17, 2022

Community approach crucial to stamp out diseases

The Karnataka Health Promotion Trust held a day-long session in New Delhi to address health care challenges


BASF to double production capacity of dispersion at its site in Indonesia
News | March 17, 2022

BASF to double production capacity of dispersion at its site in Indonesia

The expansion reiterates BASF’s continued commitment to Asia Pacific and specifically to customers in the medical glove industry


USFDA approves Rinvoq for ulcerative colitis
Drug Approval | March 17, 2022

USFDA approves Rinvoq for ulcerative colitis

First approved in 2019, Rinvoq is a JAK inhibitor approved for four indications across gastroenterology, dermatology and rheumatology


Lynparza reduced risk of death by 32% in the adjuvant treatment of patients with breast cancer
Drug Approval | March 17, 2022

Lynparza reduced risk of death by 32% in the adjuvant treatment of patients with breast cancer

First PARP inhibitor to demonstrate overall survival benefit in early breast cancer


Beghou Consulting strengthens advanced analytics and data science team in Pune
News | March 17, 2022

Beghou Consulting strengthens advanced analytics and data science team in Pune

Since 1993, Beghou Consulting has helped life sciences companies - especially emerging pharmaceutical companies - establish and manage commercial operations to better market and sell therapies


Biological E gears up for new phase of vaccination drive
News | March 17, 2022

Biological E gears up for new phase of vaccination drive

To date, 30 crore vaccines have been produced as part of the commitment made to the Government of India


Philips Capsule surveillance receives USFDA clearance
Digitisation | March 16, 2022

Philips Capsule surveillance receives USFDA clearance

Clinical surveillance solution is designed to identify emergent patient deterioration and offer enhanced patient data visibility, flexible viewing options, and clinical decision support


Nipah survivors study to advance new vaccines against highly fatal threat
Biotech | March 16, 2022

Nipah survivors study to advance new vaccines against highly fatal threat

CEPI will expand its partnership with icddr,b in Bangladesh, providing near to the additional US $ 1 million in funding to advance understanding of the Nipah virus


Experts call for capacity building to combat Antimicrobial Resistance
Sustainability | March 16, 2022

Experts call for capacity building to combat Antimicrobial Resistance

The meeting was co-organized by World Health Organization’s Country Office for India, World Animal Protection India and ReAct Asia Pacific


Wockhardt’s novel antibiotic Phase 1 trial to be conducted by NIH, USA
Biotech | March 16, 2022

Wockhardt’s novel antibiotic Phase 1 trial to be conducted by NIH, USA

The USFDA has granted a qualified infectious disease product (QIDP) designation to WCK 6777, which signifies its ability to meet unmet medical needs and facilitates a faster approval process